Population Changes in Seroprevalence among a Statewide Sample in the United States (original) (raw)
COVID-19 Antibody Seroprevalence in Santa Clara County, California
Jay Bhattacharya
2020
View PDFchevron_right
Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020
Jan Drobeniuc
MMWR. Morbidity and Mortality Weekly Report, 2020
View PDFchevron_right
Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States
Heidi Guyer
Survey research methods, 2020
View PDFchevron_right
COVID-19 symptoms and duration of direct antigen test positivity at a community testing and surveillance site, January 2021-2022
jonathan lopez lemus
View PDFchevron_right
Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020
Jay Bhattacharya
JAMA, 2020
View PDFchevron_right
The MU Study of Seropositivity and Risk for SARS-CoV-2 and COVID-19: Crucial Behavioral and Immunological Data from Midwestern College Students
Mark Daniels
2022
View PDFchevron_right
Symptoms of COVID-19 infection and magnitude of antibody response in a large community-based study
Ryan Hsieh
2021
View PDFchevron_right
Prevalence of SARS-CoV-2 antibodies during phased access to vaccination: results from a population-based survey in New York City, September 2020–March 2021
Sarah Dumas
Epidemiology and Infection
View PDFchevron_right
COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological study
Ryan Hsieh
Scientific Reports
View PDFchevron_right
Health Center Testing for SARS-CoV-2 During the COVID-19 Pandemic — United States, June 5–October 2, 2020
Xuan Le
MMWR. Morbidity and Mortality Weekly Report, 2020
View PDFchevron_right
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence in Blood in a Large School Community Subject to a Coronavirus Disease 2019 Outbreak: A Cross-sectional Study
Miguel O'Ryan
Clinical Infectious Diseases
View PDFchevron_right
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study
Andrew Dugan
2020
View PDFchevron_right
Disparities in SARS-CoV-2 exposure: evidence from a citywide seroprevalence study in Holyoke, Massachusetts, USA
Francisco Molano
2021
View PDFchevron_right
SARS-CoV-2 Viral Incidence, Antibody Point Prevalence, Associated Population Characteristics, and Vaccine Attitudes, South Carolina, February 2021
Virginie Daguise
Public Health Reports
View PDFchevron_right
Lack of Serologic Evidence of Infection Among Health Care Personnel and Other Contacts of First 2 Confirmed Patients With COVID-19 in Illinois, 2020
Hannah Kirking
Public Health Reports, 2020
View PDFchevron_right
COVID-19 vaccine antibody response is associated with side-effects, chronic health conditions, and vaccine type in a large Northern California cohort
Michelle Meas
View PDFchevron_right
COVID-19 vaccination and race – A nationwide survey of vaccination status, intentions, and trust in the US general population
Robert Morlock
Journal of managed care & specialty pharmacy, 2022
View PDFchevron_right
Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas
Hoda Hagrass
Open Forum Infectious Diseases, 2022
View PDFchevron_right
Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March–August, 2020
Jarad Schiffer
Clinical Infectious Diseases, 2021
View PDFchevron_right
Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results from Phase I of the Texas Coronavirus Antibody REsponse Survey (TX CARES)
tria eni
2021
View PDFchevron_right
Performance of Existing and Novel Symptom- and Antigen Testing-Based COVID-19 Case Definitions in a Community Setting
Hannah Kirking
View PDFchevron_right
What a difference a year makes: A snapshot of the trends in vaccinations, hospitalizations, and mortality rates for SARS- CoV-2 across the state of Indiana
chinade roper
Proceedings of IMPRS, 2021
View PDFchevron_right
COVID-19 Seroprevalence and Active Infection in an Asymptomatic Population
Charles Bogner
Frontiers in Medicine, 2021
View PDFchevron_right
Self-Reported Use of COVID-19 Immunologic Test Results to Inform Decisions About Daily Activities and COVID-19 Vaccination
Emily Svejnoha
View PDFchevron_right
Participant Demographics and Testing Trends: A Community Pandemic Response Program
Miriam Nuno
View PDFchevron_right
Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol
Hélène Blanché
Pathogens, 2021
View PDFchevron_right
Tracking COVID-19 data reporting and analysis in the United States: Findings from December, August, and May 2020
Mingqi Song
2021
View PDFchevron_right
Factors Associated with Participation in Elementary School–Based SARS-CoV-2 Testing — Salt Lake County, Utah, December 2020–January 2021
Hannah Kirking
MMWR. Morbidity and Mortality Weekly Report, 2021
View PDFchevron_right
A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children
Benjamin A Marcus
Med, 2021
View PDFchevron_right
Segmentation analysis of the unvaccinated US adult population 2 years into the COVID-19 pandemic, 1 December 2021 to 7 February 2022
Naa Botchway
Family Medicine and Community Health
View PDFchevron_right
Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey
Dr. Mark Silberman
The Journal of Infectious Diseases
View PDFchevron_right
Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia
david trump
JAMA Network Open, 2021
View PDFchevron_right
SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic
Steven Stovitz
International Journal of Infectious Diseases, 2021
View PDFchevron_right
Author response for "Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - the 2020 COVID-19 pandemic
Burcin Beken
2020
View PDFchevron_right
COVID-19 Infection, Vaccination, and Antibody Levels: Investigating Correlations through a Cohort Study
Seyfi DURMAZ
Vaccines
View PDFchevron_right